Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gap junction alpha-1 protein, also known as Connexin 43 (Cx43), is a member of the connexin family and is encoded by the GJA1 gene. It forms gap junction channels that facilitate direct communication between adjacent cells, allowing the passage of ions, metabolites, and small signaling molecules. Cx43 is crucial for maintaining tissue homeostasis and plays essential roles in cardiac function, development, immune response, and other physiological processes. Mutations in GJA1 are associated with various disorders, including oculodentodigital dysplasia, cardiac arrhythmias, and deafness. Cx43 also has channel-independent functions, such as regulating microtubule networks and protecting against apoptosis. The protein has a short half-life and is regulated by phosphorylation.
Modulation of gap junction channel permeability or expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gap junction alpha-1 protein (Cx43).